Colonic mucosal mediators from patients with irritable bowel syndrome excite enteric cholinergic motor neurons
Background Mediators released in the mucosal milieu have been suggested to be involved in visceral hypersensitivity and abdominal pain in patients with irritable bowel syndrome (IBS). However, their impact on myenteric neurons remains unsettled. Methods Mucosal biopsies were obtained from the desc...
Saved in:
Published in: | Neurogastroenterology and motility Vol. 24; no. 12; pp. 1118 - e570 |
---|---|
Main Authors: | , , , , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Oxford, UK
Blackwell Publishing Ltd
01-12-2012
Wiley Subscription Services, Inc |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Abstract | Background Mediators released in the mucosal milieu have been suggested to be involved in visceral hypersensitivity and abdominal pain in patients with irritable bowel syndrome (IBS). However, their impact on myenteric neurons remains unsettled.
Methods Mucosal biopsies were obtained from the descending colon of patients with IBS and controls. Mucosal mast cells were identified immunohistochemically. The impact of spontaneously released mucosal mediators on guinea pig electrically stimulated longitudinal muscle myenteric plexus (LMMP) preparations was assessed in vitro by means of selective receptor antagonists and inhibitors.
Key Results Patients with IBS showed an increased mast cell count compared with controls. Application of mucosal mediators of IBS to LMMPs potentiated cholinergic twitch contractions, an effect directly correlated with mast cell counts. Enhanced contractions were inhibited by 50.3% with the prostaglandin D2 antagonist BW A868C, by 31.3% and 39% with the TRPV1 antagonists capsazepine and HC‐030031, respectively, and by 60.5% with purinergic P2X antagonist pyridoxalphosphate‐6‐azophenyl‐2′,4′‐disulfonic acid. Conversely, the serotonin1‐4, histamine1‐3, tachykinin1‐3 receptor blockade, and serine protease inhibition had no significant effect.
Conclusions & Inferences Colonic mucosal mediators from patients with IBS excite myenteric cholinergic motor neurons. These effects were correlated with mast cell counts and mediated by activation of prostanoid receptors, TRPV1, and P2X receptors. These results support the role of mucosal inflammatory mediators and mast cell activation in altered motor function of IBS. |
---|---|
AbstractList | Background
Mediators released in the mucosal milieu have been suggested to be involved in visceral hypersensitivity and abdominal pain in patients with irritable bowel syndrome (IBS). However, their impact on myenteric neurons remains unsettled.
Methods
Mucosal biopsies were obtained from the descending colon of patients with IBS and controls. Mucosal mast cells were identified immunohistochemically. The impact of spontaneously released mucosal mediators on guinea pig electrically stimulated longitudinal muscle myenteric plexus (LMMP) preparations was assessed
in vitro
by means of selective receptor antagonists and inhibitors.
Key Results
Patients with IBS showed an increased mast cell count compared with controls. Application of mucosal mediators of IBS to LMMPs potentiated cholinergic twitch contractions, an effect directly correlated with mast cell counts. Enhanced contractions were inhibited by 50.3% with the prostaglandin D2 antagonist BW A868C, by 31.3% and 39% with the TRPV1 antagonists capsazepine and HC‐030031, respectively, and by 60.5% with purinergic P2X antagonist pyridoxalphosphate‐6‐azophenyl‐2′,4′‐disulfonic acid. Conversely, the serotonin1‐4, histamine1‐3, tachykinin1‐3 receptor blockade, and serine protease inhibition had no significant effect.
Conclusions & Inferences
Colonic mucosal mediators from patients with IBS excite myenteric cholinergic motor neurons. These effects were correlated with mast cell counts and mediated by activation of prostanoid receptors, TRPV1, and P2X receptors. These results support the role of mucosal inflammatory mediators and mast cell activation in altered motor function of IBS. Background Mediators released in the mucosal milieu have been suggested to be involved in visceral hypersensitivity and abdominal pain in patients with irritable bowel syndrome (IBS). However, their impact on myenteric neurons remains unsettled. Methods Mucosal biopsies were obtained from the descending colon of patients with IBS and controls. Mucosal mast cells were identified immunohistochemically. The impact of spontaneously released mucosal mediators on guinea pig electrically stimulated longitudinal muscle myenteric plexus (LMMP) preparations was assessed in vitro by means of selective receptor antagonists and inhibitors. Key Results Patients with IBS showed an increased mast cell count compared with controls. Application of mucosal mediators of IBS to LMMPs potentiated cholinergic twitch contractions, an effect directly correlated with mast cell counts. Enhanced contractions were inhibited by 50.3% with the prostaglandin D2 antagonist BW A868C, by 31.3% and 39% with the TRPV1 antagonists capsazepine and HC‐030031, respectively, and by 60.5% with purinergic P2X antagonist pyridoxalphosphate‐6‐azophenyl‐2′,4′‐disulfonic acid. Conversely, the serotonin1‐4, histamine1‐3, tachykinin1‐3 receptor blockade, and serine protease inhibition had no significant effect. Conclusions & Inferences Colonic mucosal mediators from patients with IBS excite myenteric cholinergic motor neurons. These effects were correlated with mast cell counts and mediated by activation of prostanoid receptors, TRPV1, and P2X receptors. These results support the role of mucosal inflammatory mediators and mast cell activation in altered motor function of IBS. Background Mediators released in the mucosal milieu have been suggested to be involved in visceral hypersensitivity and abdominal pain in patients with irritable bowel syndrome (IBS). However, their impact on myenteric neurons remains unsettled. Methods Mucosal biopsies were obtained from the descending colon of patients with IBS and controls. Mucosal mast cells were identified immunohistochemically. The impact of spontaneously released mucosal mediators on guinea pig electrically stimulated longitudinal muscle myenteric plexus (LMMP) preparations was assessed in vitro by means of selective receptor antagonists and inhibitors. Key Results Patients with IBS showed an increased mast cell count compared with controls. Application of mucosal mediators of IBS to LMMPs potentiated cholinergic twitch contractions, an effect directly correlated with mast cell counts. Enhanced contractions were inhibited by 50.3% with the prostaglandin D2 antagonist BW A868C, by 31.3% and 39% with the TRPV1 antagonists capsazepine and HC-030031, respectively, and by 60.5% with purinergic P2X antagonist pyridoxalphosphate-6-azophenyl-2',4'-disulfonic acid. Conversely, the serotonin1-4, histamine1-3, tachykinin1-3 receptor blockade, and serine protease inhibition had no significant effect. Conclusions & Inferences Colonic mucosal mediators from patients with IBS excite myenteric cholinergic motor neurons. These effects were correlated with mast cell counts and mediated by activation of prostanoid receptors, TRPV1, and P2X receptors. These results support the role of mucosal inflammatory mediators and mast cell activation in altered motor function of IBS. Mediators released in the mucosal milieu have been suggested to be involved in visceral hypersensitivity and abdominal pain in patients with irritable bowel syndrome (IBS). However, their impact on myenteric neurons remains unsettled. Mucosal biopsies were obtained from the descending colon of patients with IBS and controls. Mucosal mast cells were identified immunohistochemically. The impact of spontaneously released mucosal mediators on guinea pig electrically stimulated longitudinal muscle myenteric plexus (LMMP) preparations was assessed in vitro by means of selective receptor antagonists and inhibitors. Patients with IBS showed an increased mast cell count compared with controls. Application of mucosal mediators of IBS to LMMPs potentiated cholinergic twitch contractions, an effect directly correlated with mast cell counts. Enhanced contractions were inhibited by 50.3% with the prostaglandin D2 antagonist BW A868C, by 31.3% and 39% with the TRPV1 antagonists capsazepine and HC-030031, respectively, and by 60.5% with purinergic P2X antagonist pyridoxalphosphate-6-azophenyl-2',4'-disulfonic acid. Conversely, the serotonin1-4, histamine1-3, tachykinin1-3 receptor blockade, and serine protease inhibition had no significant effect. Colonic mucosal mediators from patients with IBS excite myenteric cholinergic motor neurons. These effects were correlated with mast cell counts and mediated by activation of prostanoid receptors, TRPV1, and P2X receptors. These results support the role of mucosal inflammatory mediators and mast cell activation in altered motor function of IBS. Background Mediators released in the mucosal milieu have been suggested to be involved in visceral hypersensitivity and abdominal pain in patients with irritable bowel syndrome (IBS). However, their impact on myenteric neurons remains unsettled. Methods Mucosal biopsies were obtained from the descending colon of patients with IBS and controls. Mucosal mast cells were identified immunohistochemically. The impact of spontaneously released mucosal mediators on guinea pig electrically stimulated longitudinal muscle myenteric plexus (LMMP) preparations was assessed in vitro by means of selective receptor antagonists and inhibitors. Key Results Patients with IBS showed an increased mast cell count compared with controls. Application of mucosal mediators of IBS to LMMPs potentiated cholinergic twitch contractions, an effect directly correlated with mast cell counts. Enhanced contractions were inhibited by 50.3% with the prostaglandin D2 antagonist BW A868C, by 31.3% and 39% with the TRPV1 antagonists capsazepine and HC-030031, respectively, and by 60.5% with purinergic P2X antagonist pyridoxalphosphate-6-azophenyl-2',4'-disulfonic acid. Conversely, the serotonin1-4, histamine1-3, tachykinin1-3 receptor blockade, and serine protease inhibition had no significant effect. Conclusions & Inferences Colonic mucosal mediators from patients with IBS excite myenteric cholinergic motor neurons. These effects were correlated with mast cell counts and mediated by activation of prostanoid receptors, TRPV1, and P2X receptors. These results support the role of mucosal inflammatory mediators and mast cell activation in altered motor function of IBS. [PUBLICATION ABSTRACT] |
Author | Zecchi, L. Tonini, M. Cremon, C. Vasina, V. Balestra, B. Vicini, R. Paccapelo, A. Corinaldesi, R. De Giorgio, R. Pastoris, O. De Ponti, F. Barbara, G. Stanghellini, V. Dothel, G. |
Author_xml | – sequence: 1 givenname: B. surname: Balestra fullname: Balestra, B. organization: Department of Forensic Medicine, Pharmacology and Toxicology, University of Pavia, Pavia, Italy – sequence: 2 givenname: R. surname: Vicini fullname: Vicini, R. organization: Department of Forensic Medicine, Pharmacology and Toxicology, University of Pavia, Pavia, Italy – sequence: 3 givenname: C. surname: Cremon fullname: Cremon, C. organization: Department of Clinical Medicine and Center for Applied Biomedical Research (CRBA), University of Bologna, Bologna, Italy – sequence: 4 givenname: L. surname: Zecchi fullname: Zecchi, L. organization: Department of Clinical Medicine and Center for Applied Biomedical Research (CRBA), University of Bologna, Bologna, Italy – sequence: 5 givenname: G. surname: Dothel fullname: Dothel, G. organization: Department of Pharmacology, University of Bologna, Bologna, Italy – sequence: 6 givenname: V. surname: Vasina fullname: Vasina, V. organization: Department of Pharmacology, University of Bologna, Bologna, Italy – sequence: 7 givenname: R. surname: De Giorgio fullname: De Giorgio, R. organization: Department of Clinical Medicine and Center for Applied Biomedical Research (CRBA), University of Bologna, Bologna, Italy – sequence: 8 givenname: A. surname: Paccapelo fullname: Paccapelo, A. organization: Department of Clinical Medicine and Center for Applied Biomedical Research (CRBA), University of Bologna, Bologna, Italy – sequence: 9 givenname: O. surname: Pastoris fullname: Pastoris, O. organization: Department of Forensic Medicine, Pharmacology and Toxicology, University of Pavia, Pavia, Italy – sequence: 10 givenname: V. surname: Stanghellini fullname: Stanghellini, V. organization: Department of Clinical Medicine and Center for Applied Biomedical Research (CRBA), University of Bologna, Bologna, Italy – sequence: 11 givenname: R. surname: Corinaldesi fullname: Corinaldesi, R. organization: Department of Clinical Medicine and Center for Applied Biomedical Research (CRBA), University of Bologna, Bologna, Italy – sequence: 12 givenname: F. surname: De Ponti fullname: De Ponti, F. organization: Department of Pharmacology, University of Bologna, Bologna, Italy – sequence: 13 givenname: M. surname: Tonini fullname: Tonini, M. organization: Department of Forensic Medicine, Pharmacology and Toxicology, University of Pavia, Pavia, Italy – sequence: 14 givenname: G. surname: Barbara fullname: Barbara, G. organization: Department of Clinical Medicine and Center for Applied Biomedical Research (CRBA), University of Bologna, Bologna, Italy |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/22937879$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kU1v1DAQhi1URD_gwB9AlriUQ1p_xHFyhFVpkbbbC1UlLpbtTKhLYi-2o-3-e7xs2wMSc5mx9Mwja95jdOCDB4TeU3JGS537KZxRRgh5hY4ob0TFupYd7GZBKtoxcYiOU3ooQMPq5g06ZKzjspXdEfKLMAbvLJ5mG5Ie8QS90znEhIcYJrzW2YHPCW9cvscuRpe1GQGbsIERp63vCwUYHq3LpfkMscjsfRidh_hzJw7Fhj3MMfj0Fr0e9Jjg3VM_QbdfL74vrqrlzeW3xedlZWtWk6omoC0MRDDZEugF7yU1vDc9r40ECkIyyfnADNW2hq4hwHV5w2AMJQMwfoJO9951DL9nSFlNLlkYR-0hzElRJqSsW8ZoQT_-gz6EOfryO0VpJ2sqGtkW6tOesjGkFGFQ6-gmHbeKErULQZUQ1N8QCvvhyTibcs4X8vnqBTjfAxs3wvb_JrW6vnlWVvsNlzI8vmzo-Es1kkuh7laXqrn-8mO5uloqwf8APo-j3Q |
CitedBy_id | crossref_primary_10_1016_j_lfs_2014_12_017 crossref_primary_10_1038_srep25203 crossref_primary_10_1371_journal_pone_0080925 crossref_primary_10_1080_13543784_2018_1442434 crossref_primary_10_1111_nmo_14595 crossref_primary_10_1111_nmo_12928 crossref_primary_10_1016_j_jcmgh_2018_02_001 crossref_primary_10_1007_s11302_013_9397_9 crossref_primary_10_1038_ajg_2015_158 crossref_primary_10_1111_nmo_14634 crossref_primary_10_1111_nmo_12525 crossref_primary_10_1111_1751_2980_12379 crossref_primary_10_1111_apt_13283 crossref_primary_10_1097_MPG_0000000000003588 crossref_primary_10_1016_j_jphs_2023_02_001 crossref_primary_10_1152_ajpgi_00144_2015 crossref_primary_10_1111_1751_2980_12971 crossref_primary_10_1111_nmo_13192 crossref_primary_10_1111_nmo_13157 crossref_primary_10_1007_s00436_018_5792_z crossref_primary_10_33805_2690_2613_110 crossref_primary_10_5056_jnm21132 crossref_primary_10_1136_gutjnl_2015_309151 crossref_primary_10_3748_wjg_v22_i45_9871 crossref_primary_10_5056_jnm15137 crossref_primary_10_3748_wjg_v22_i46_10198 crossref_primary_10_1111_bph_12989 crossref_primary_10_1038_ajg_2013_245 crossref_primary_10_3390_gidisord3040016 crossref_primary_10_1136_gutjnl_2015_311339 crossref_primary_10_3390_ijms24087440 crossref_primary_10_5056_jnm20175 crossref_primary_10_1097_MOG_0000000000000070 crossref_primary_10_1111_nmo_12039 crossref_primary_10_1053_j_gastro_2013_01_040 crossref_primary_10_1111_nmo_13718 crossref_primary_10_3389_fncel_2015_00452 crossref_primary_10_1007_s11011_023_01187_6 crossref_primary_10_3390_jcm10153429 crossref_primary_10_1080_15384101_2015_1093712 crossref_primary_10_1038_nrgastro_2014_127 crossref_primary_10_3389_fnins_2023_934341 crossref_primary_10_1186_s12967_023_04215_2 crossref_primary_10_3389_fmed_2023_1083351 crossref_primary_10_1038_nrgastro_2014_200 crossref_primary_10_1111_nmo_13579 crossref_primary_10_1111_nmo_12316 crossref_primary_10_3389_fnins_2015_00465 crossref_primary_10_3389_fphar_2021_596686 crossref_primary_10_15406_ghoa_2020_11_00412 crossref_primary_10_1155_2018_9252984 crossref_primary_10_3390_molecules25184314 crossref_primary_10_1136_gutjnl_2012_304066 crossref_primary_10_1155_2016_2031480 crossref_primary_10_1136_gutjnl_2014_308188 crossref_primary_10_22141_2308_2097_55_2_2021_233635 |
Cites_doi | 10.1111/j.1365-2982.2005.00685.x 10.1016/j.tips.2007.08.003 10.1159/000268131 10.1053/j.gastro.2004.02.017 10.1136/gut.2004.048876 10.1016/0014-2999(96)00037-4 10.1136/gut.2006.100594 10.1113/jphysiol.1982.sp014407 10.1113/jphysiol.1968.sp008392 10.1182/blood.V97.3.587 10.1152/physrev.00043.2006 10.1136/gut.2008.169250 10.1111/j.1476-5381.2009.00287.x 10.1007/BF01303164 10.1016/j.ejphar.2004.07.020 10.1097/00042737-200410000-00010 10.7326/0003-4819-111-8-671 10.1007/s00210-005-0021-6 10.1038/ajg.2008.94 10.1053/j.gastro.2005.11.061 10.1056/NEJMcp0801447 10.1136/gut.45.2008.ii43 10.1111/j.1365-2982.2008.01100.x 10.1111/j.1365-2036.2011.04684.x 10.1111/j.1365-2982.2004.00591.x 10.1111/j.1572-0241.2002.05475.x 10.1136/gut.2007.138982 10.2174/138161209788186335 10.1002/cne.10801 10.1113/jphysiol.2004.060848 10.1172/JCI29255 10.1136/gut.2010.213108 10.1053/j.gastro.2009.07.005 10.1136/gut.29.3.342 10.1053/j.gastro.2003.11.055 10.1038/sj.bjp.0705768 10.1053/j.gastro.2009.02.074 10.1038/ajg.2011.423 10.1111/j.1365-2982.2008.01259.x 10.1136/gut.51.suppl_1.i41 10.1523/JNEUROSCI.22-12-04767.2002 10.1016/j.jneuroim.2007.09.013 10.1111/j.1365-2036.2009.04041.x 10.1053/j.gastro.2006.11.039 10.1016/S1471-4892(02)00215-1 |
ContentType | Journal Article |
Copyright | 2012 Blackwell Publishing Ltd 2012 Blackwell Publishing Ltd. |
Copyright_xml | – notice: 2012 Blackwell Publishing Ltd – notice: 2012 Blackwell Publishing Ltd. |
DBID | BSCLL CGR CUY CVF ECM EIF NPM AAYXX CITATION 7TK K9. |
DOI | 10.1111/nmo.12000 |
DatabaseName | Istex Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Neurosciences Abstracts ProQuest Health & Medical Complete (Alumni) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef ProQuest Health & Medical Complete (Alumni) Neurosciences Abstracts |
DatabaseTitleList | CrossRef Neurosciences Abstracts MEDLINE ProQuest Health & Medical Complete (Alumni) |
Database_xml | – sequence: 1 dbid: ECM name: MEDLINE url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Anatomy & Physiology |
EISSN | 1365-2982 |
EndPage | e570 |
ExternalDocumentID | 2824341781 10_1111_nmo_12000 22937879 NMO12000 ark_67375_WNG_6MBZLNHL_5 |
Genre | article Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- .3N .GA .Y3 05W 0R~ 10A 123 1OB 1OC 24P 29N 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5HH 5LA 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAKAS AANLZ AAONW AASGY AAXRX AAZKR ABCQN ABCUV ABDBF ABEML ABOCM ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZCM ADZMN AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFPM AFGKR AFPWT AFZJQ AHBTC AHEFC AHMBA AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ATUGU AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BSCLL BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DTERQ DU5 EAD EAP EAS EBC EBD EBS EBX EJD EMB EMK EMOBN EPT ESX EX3 F00 F01 F04 F5P FEDTE FUBAC FZ0 G-S G.N GODZA H.X HF~ HGLYW HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 Q~Q R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ SV3 TEORI TUS UB1 W8V W99 WBKPD WHWMO WIH WIJ WIK WIN WOHZO WOW WQJ WRC WVDHM WXI WXSBR XG1 YFH ZZTAW ~IA ~WT CGR CUY CVF ECM EIF NPM AAMNL AAYXX CITATION 7TK K9. |
ID | FETCH-LOGICAL-c4240-40eacef052780ed53d71b3dbd34b7e1e572733f2b1ac4e960e3a33fefbb10fe23 |
IEDL.DBID | 33P |
ISSN | 1350-1925 |
IngestDate | Thu Aug 15 23:50:18 EDT 2024 Tue Nov 19 06:34:28 EST 2024 Thu Nov 21 22:27:42 EST 2024 Tue Aug 27 13:46:44 EDT 2024 Sat Aug 24 01:09:08 EDT 2024 Wed Oct 30 09:55:48 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 12 |
Language | English |
License | 2012 Blackwell Publishing Ltd. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4240-40eacef052780ed53d71b3dbd34b7e1e572733f2b1ac4e960e3a33fefbb10fe23 |
Notes | ark:/67375/WNG-6MBZLNHL-5 ArticleID:NMO12000 istex:B646DBF6669CA79FF45A260E37FA109B0A2874DD These authors equally contributed to the manuscript. ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
PMID | 22937879 |
PQID | 1197415678 |
PQPubID | 1006536 |
PageCount | 10 |
ParticipantIDs | proquest_miscellaneous_1257748221 proquest_journals_1197415678 crossref_primary_10_1111_nmo_12000 pubmed_primary_22937879 wiley_primary_10_1111_nmo_12000_NMO12000 istex_primary_ark_67375_WNG_6MBZLNHL_5 |
PublicationCentury | 2000 |
PublicationDate | 2012-12 December 2012 2012-Dec 2012-12-00 20121201 |
PublicationDateYYYYMMDD | 2012-12-01 |
PublicationDate_xml | – month: 12 year: 2012 text: 2012-12 |
PublicationDecade | 2010 |
PublicationPlace | Oxford, UK |
PublicationPlace_xml | – name: Oxford, UK – name: England – name: Oxford |
PublicationTitle | Neurogastroenterology and motility |
PublicationTitleAlternate | Neurogastroenterol Motil |
PublicationYear | 2012 |
Publisher | Blackwell Publishing Ltd Wiley Subscription Services, Inc |
Publisher_xml | – name: Blackwell Publishing Ltd – name: Wiley Subscription Services, Inc |
References | Boeckxstaens GE, de Jonge WJ. Neuroimmune mechanisms in postoperative ileus. Gut 2009; 58: 1300-11. Bartho L, Holzer P, Lembeck F, Szolcsanyi J. Evidence that the contractile response of the guinea-pig ileum to capsaicin is due to release of substance P. J Physiol 1982; 332: 157-67. Barbara G, Stanghellini V, De Giorgio R, Corinaldesi R. Functional gastrointestinal disorders and mast cells: implications for therapy. Neurogastroenterol Motil 2006; 18: 6-17. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006; 130: 1480-91. Liu YJ, Jackson DM, Blackham A. Effects of BW A868C, a selective prostaglandin DP receptor antagonist, in dog isolated vascular preparations. Eur J Pharmacol 1996; 303: 187-92. Corinaldesi R, Stanghellini V, Cremon C et al. Effect of mesalazine on mucosal immune biomarkers in irritable bowel syndrome: a randomized controlled proof-of-concept study. Aliment Pharmacol Ther 2009; 30: 245-52. Di Virgilio F, Chiozzi P, Ferrari D et al. Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood 2001; 97: 587-600. Monro RL, Bertrand PP, Bornstein JC. ATP participates in three excitatory postsynaptic potentials in the submucous plexus of the guinea pig ileum. J Physiol 2004; 556: 571-84. Spiller R, Garsed K. Postinfectious irritable bowel syndrome. Gastroenterology 2009; 136: 1979-88. Dekkers JA, Akkermans LM, Kroese AB. Effects of the inflammatory mediator prostaglandin E2 on myenteric neurons in guinea pig ileum. Am J Physiol 1997; 272: G1451-6. Dunlop SP, Jenkins D, Spiller RC. Age-related decline in rectal mucosal lymphocytes and mast cells. Eur J Gastroenterol Hepatol 2004; 16: 1011-5. Wareham K, Vial C, Wykes RC, Bradding P, Seward EP. Functional evidence for the expression of P2X1, P2X4 and P2X7 receptors in human lung mast cells. Br J Pharmacol 2009; 157: 1215-24. Ward SM, Bayguinov J, Won KJ, Grundy D, Berthoud HR. Distribution of the vanilloid receptor (VR1) in the gastrointestinal tract. J Comp Neurol 2003; 465: 121-35. Bassotti G, Villanacci V, Nascimbeni R et al. Colonic mast cells in controls and slow transit constipation patients. Aliment Pharmacol Ther 2011; 34: 92-9. Wood JD. Enteric neuroimmunophysiology and pathophysiology. Gastroenterology 2004; 127: 635-57. Mayer EA. Clinical practice. Irritable bowel syndrome. N Engl J Med 2008; 358: 1692-9. Chang L, Adeyemo M, Karagiannides I et al. Serum and colonic mucosal immune markers in irritable bowel syndrome. Am J Gastroenterol 2012; 107: 262-72. Geber C, Mang CF, Kilbinger H. Facilitation and inhibition by capsaicin of cholinergic neurotransmission in the guinea-pig small intestine. Naunyn Schmiedebergs Arch Pharmacol 2006; 372: 277-83. Barbara G, Stanghellini V, De Giorgio R et al. Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology 2004; 126: 693-702. Barbara G, Wang B, Stanghellini V et al. Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome. Gastroenterology 2007; 132: 26-37. Suzuki R, Furuno T, Okamoto K, Teshima R, Nakanishi M. ATP plays a role in neurite stimulation with activated mast cells. J Neuroimmunol 2007; 192: 49-56. Buhner S, Li Q, Vignali S et al. Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome. Gastroenterology 2009; 137: 1425-34. Simren M, Axelsson J, Gillberg R, Abrahamsson H, Svedlund J, Bjornsson ES. Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors. Am J Gastroenterol 2002; 97: 389-96. Burnstock G. Physiology and pathophysiology of purinergic neurotransmission. Physiol Rev 2007; 87: 659-797. Vergnolle N. Clinical relevance of proteinase activated receptors (pars) in the gut. Gut 2005; 54: 867-74. Klooker TK, Braak B, Koopman KE et al. The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome. Gut 2010; 59: 1213-21. Paton WD, Zar MA. The origin of acetylcholine released from guinea-pig intestine and longitudinal muscle strips. J Physiol 1968; 194: 13-33. Sharif NA, Crider JY, Xu SX, Williams GW. Affinities, selectivities, potencies, and intrinsic activities of natural and synthetic prostanoids using endogenous receptors: focus on DP class prostanoids. J Pharmacol Exp Ther 2000; 293: 321-8. Talley NJ, Phillips SF, Melton J 3rd, Wiltgen C, Zinsmeister AR. A patient questionnaire to identify bowel disease. Ann Intern Med 1989; 111: 671-4. Steck N, Mueller K, Schemann M, Haller D. Bacterial proteases in IBD and IBS. Gut 2011; doi: 10.1136/gutjnl-2011-300775. Cenac N, Andrews CN, Holzhausen M et al. Role for protease activity in visceral pain in irritable bowel syndrome. J Clin Invest 2007; 117: 636-47. Bartho L, Benko R, Patacchini R et al. Effects of capsaicin on visceral smooth muscle: a valuable tool for sensory neurotransmitter identification. Eur J Pharmacol 2004; 500: 143-57. Burnstock G. Purinergic receptors and pain. Curr Pharm Des 2009; 15: 1717-35. Weston AP, Biddle WL, Bhatia PS, Miner PB Jr. Terminal ileal mucosal mast cells in irritable bowel syndrome. Dig Dis Sci 1993; 38: 1590-5. Rao SS, Holdsworth CD, Read NW. Symptoms and stool patterns in patients with ulcerative colitis. Gut 1988; 29: 342-5. Geppetti P, Trevisani M. Activation and sensitisation of the vanilloid receptor: role in gastrointestinal inflammation and function. Br J Pharmacol 2004; 141: 1313-20. Rong W, Keating C, Sun B, Dong L, Grundy D. Purinergic contribution to small intestinal afferent hypersensitivity in a murine model of postinfectious bowel disease. Neurogastroenterol Motil 2009; 21: 665-71. Buhner S, Li Q, Berger T et al. Submucous rather than myenteric neurons are activated by supernatants of mucosal biopsies from IBS patients. Neurogastroenterol Motil 2010; 22: 1. Kerckhoffs AP, Ter Linde JJ, Akkermans LM, Samsom M. Trypsinogen IV, serotonin transporter transcript levels and serotonin content are increased in small intestine of irritable bowel syndrome patients. Neurogastroenterol Motil 2008; 20: 900-7. De Giorgio R, Barbara G, Furness JB, Tonini M. Novel therapeutic targets for enteric nervous system disorders. Trends Pharmacol Sci 2007; 28: 473-81. Schemann M, Michel K, Ceregrzyn M, Zeller F, Seidl S, Bischoff SC. Human mast cell mediator cocktail excites neurons in human and guinea-pig enteric nervous system. Neurogastroenterol Motil 2005; 17: 281-9. Guilarte M, Santos J, de Torres I et al. Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum. Gut 2007; 56: 203-9. Frieling T, Rupprecht C, Kroese AB, Schemann M. Effects of the inflammatory mediator prostaglandin D2 on submucosal neurons and secretion in guinea pig colon. Am J Physiol 1994; 266: G132-9. Akbar A, Yiangou Y, Facer P, Walters JR, Anand P, Ghosh S. Increased capsaicin receptor TRPV1-expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain. Gut 2008; 57: 923-9. Cremon C, Gargano L, Morselli-Labate AM et al. Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms. Am J Gastroenterol 2009; 104: 392-400. Barbara G, Stanghellini V, Cremon C et al. Aminosalicylates and other anti-inflammatory compounds for irritable bowel syndrome. Dig Dis 2009; 27(Suppl. 1): 115-21. Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Muller-Lissner SA. Functional bowel disorders and functional abdominal pain. Gut 1999; 45(Suppl. 2): II43-7. Sharkey KA, Mawe GM. Neuroimmune and epithelial interactions in intestinal inflammation. Curr Opin Pharmacol 2002; 2: 669-77. Barbara G, De Giorgio R, Stanghellini V, Cremon C, Corinaldesi R. A role for inflammation in irritable bowel syndrome? Gut 2002; 51(Suppl. 1): i41-4. Bertrand PP, Bornstein JC. ATP as a putative sensory mediator: activation of intrinsic sensory neurons of the myenteric plexus via P2X receptors. J Neurosci 2002; 22: 4767-75. 2004; 127 2004; 126 2010; 59 2002; 97 1997; 272 2002; 51 1989; 111 2006; 130 2006; 372 1999; 45 2000; 293 2009; 157 1996; 303 1994; 266 2007; 28 2010; 22 2009; 58 1993; 38 2007; 132 1982; 332 2008; 358 2008; 20 2009; 15 2001; 97 2004; 500 2009; 21 2011 2004; 141 2002; 2 2006; 18 2008; 57 2011; 34 1968; 194 2007; 56 2009; 136 2012; 107 2009; 27 2009; 137 2004; 556 2009; 30 2007; 117 1988; 29 2007; 192 2004; 16 2002; 22 2005; 54 2007; 87 2005; 17 2003; 465 2009; 104 e_1_2_10_23_2 e_1_2_10_21_2 e_1_2_10_40_2 Dekkers JA (e_1_2_10_41_2) 1997; 272 e_1_2_10_2_2 e_1_2_10_18_2 e_1_2_10_39_2 e_1_2_10_4_2 e_1_2_10_16_2 e_1_2_10_37_2 e_1_2_10_6_2 e_1_2_10_14_2 e_1_2_10_35_2 e_1_2_10_11_2 e_1_2_10_34_2 e_1_2_10_8_2 e_1_2_10_32_2 e_1_2_10_30_2 e_1_2_10_51_2 e_1_2_10_29_2 e_1_2_10_27_2 e_1_2_10_48_2 e_1_2_10_25_2 e_1_2_10_46_2 e_1_2_10_22_2 e_1_2_10_45_2 Sharif NA (e_1_2_10_20_2) 2000; 293 e_1_2_10_43_2 e_1_2_10_19_2 e_1_2_10_3_2 e_1_2_10_17_2 e_1_2_10_5_2 e_1_2_10_15_2 e_1_2_10_38_2 Steck N (e_1_2_10_24_2) 2011 e_1_2_10_7_2 e_1_2_10_13_2 e_1_2_10_36_2 e_1_2_10_9_2 e_1_2_10_12_2 e_1_2_10_33_2 e_1_2_10_10_2 e_1_2_10_31_2 e_1_2_10_50_2 Frieling T (e_1_2_10_42_2) 1994; 266 Buhner S (e_1_2_10_44_2) 2010; 22 e_1_2_10_28_2 e_1_2_10_26_2 e_1_2_10_49_2 e_1_2_10_47_2 |
References_xml | – volume: 157 start-page: 1215 year: 2009 end-page: 24 article-title: Functional evidence for the expression of P2X1, P2X4 and P2X7 receptors in human lung mast cells publication-title: Br J Pharmacol – volume: 27 start-page: 115 issue: Suppl. 1 year: 2009 end-page: 21 article-title: Aminosalicylates and other anti‐inflammatory compounds for irritable bowel syndrome publication-title: Dig Dis – volume: 58 start-page: 1300 year: 2009 end-page: 11 article-title: Neuroimmune mechanisms in postoperative ileus publication-title: Gut – volume: 126 start-page: 693 year: 2004 end-page: 702 article-title: Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome publication-title: Gastroenterology – volume: 372 start-page: 277 year: 2006 end-page: 83 article-title: Facilitation and inhibition by capsaicin of cholinergic neurotransmission in the guinea‐pig small intestine publication-title: Naunyn Schmiedebergs Arch Pharmacol – volume: 266 start-page: G132 year: 1994 end-page: 9 article-title: Effects of the inflammatory mediator prostaglandin D2 on submucosal neurons and secretion in guinea pig colon publication-title: Am J Physiol – volume: 104 start-page: 392 year: 2009 end-page: 400 article-title: Mucosal immune activation in irritable bowel syndrome: gender‐dependence and association with digestive symptoms publication-title: Am J Gastroenterol – volume: 20 start-page: 900 year: 2008 end-page: 7 article-title: Trypsinogen IV, serotonin transporter transcript levels and serotonin content are increased in small intestine of irritable bowel syndrome patients publication-title: Neurogastroenterol Motil – volume: 16 start-page: 1011 year: 2004 end-page: 5 article-title: Age‐related decline in rectal mucosal lymphocytes and mast cells publication-title: Eur J Gastroenterol Hepatol – volume: 500 start-page: 143 year: 2004 end-page: 57 article-title: Effects of capsaicin on visceral smooth muscle: a valuable tool for sensory neurotransmitter identification publication-title: Eur J Pharmacol – volume: 29 start-page: 342 year: 1988 end-page: 5 article-title: Symptoms and stool patterns in patients with ulcerative colitis publication-title: Gut – volume: 130 start-page: 1480 year: 2006 end-page: 91 article-title: Functional bowel disorders publication-title: Gastroenterology – volume: 57 start-page: 923 year: 2008 end-page: 9 article-title: Increased capsaicin receptor TRPV1‐expressing sensory fibres in irritable bowel syndrome and their correlation with abdominal pain publication-title: Gut – volume: 136 start-page: 1979 year: 2009 end-page: 88 article-title: Postinfectious irritable bowel syndrome publication-title: Gastroenterology – volume: 56 start-page: 203 year: 2007 end-page: 9 article-title: Diarrhoea‐predominant IBS patients show mast cell activation and hyperplasia in the jejunum publication-title: Gut – volume: 54 start-page: 867 year: 2005 end-page: 74 article-title: Clinical relevance of proteinase activated receptors (pars) in the gut publication-title: Gut – volume: 303 start-page: 187 year: 1996 end-page: 92 article-title: Effects of BW A868C, a selective prostaglandin DP receptor antagonist, in dog isolated vascular preparations publication-title: Eur J Pharmacol – volume: 132 start-page: 26 year: 2007 end-page: 37 article-title: Mast cell‐dependent excitation of visceral‐nociceptive sensory neurons in irritable bowel syndrome publication-title: Gastroenterology – volume: 28 start-page: 473 year: 2007 end-page: 81 article-title: Novel therapeutic targets for enteric nervous system disorders publication-title: Trends Pharmacol Sci – volume: 97 start-page: 389 year: 2002 end-page: 96 article-title: Quality of life in inflammatory bowel disease in remission: the impact of IBS‐like symptoms and associated psychological factors publication-title: Am J Gastroenterol – volume: 293 start-page: 321 year: 2000 end-page: 8 article-title: Affinities, selectivities, potencies, and intrinsic activities of natural and synthetic prostanoids using endogenous receptors: focus on DP class prostanoids publication-title: J Pharmacol Exp Ther – volume: 117 start-page: 636 year: 2007 end-page: 47 article-title: Role for protease activity in visceral pain in irritable bowel syndrome publication-title: J Clin Invest – volume: 556 start-page: 571 year: 2004 end-page: 84 article-title: ATP participates in three excitatory postsynaptic potentials in the submucous plexus of the guinea pig ileum publication-title: J Physiol – volume: 137 start-page: 1425 year: 2009 end-page: 34 article-title: Activation of human enteric neurons by supernatants of colonic biopsy specimens from patients with irritable bowel syndrome publication-title: Gastroenterology – volume: 59 start-page: 1213 year: 2010 end-page: 21 article-title: The mast cell stabiliser ketotifen decreases visceral hypersensitivity and improves intestinal symptoms in patients with irritable bowel syndrome publication-title: Gut – volume: 465 start-page: 121 year: 2003 end-page: 35 article-title: Distribution of the vanilloid receptor (VR1) in the gastrointestinal tract publication-title: J Comp Neurol – volume: 97 start-page: 587 year: 2001 end-page: 600 article-title: Nucleotide receptors: an emerging family of regulatory molecules in blood cells publication-title: Blood – volume: 141 start-page: 1313 year: 2004 end-page: 20 article-title: Activation and sensitisation of the vanilloid receptor: role in gastrointestinal inflammation and function publication-title: Br J Pharmacol – volume: 358 start-page: 1692 year: 2008 end-page: 9 article-title: Clinical practice. Irritable bowel syndrome publication-title: N Engl J Med – volume: 2 start-page: 669 year: 2002 end-page: 77 article-title: Neuroimmune and epithelial interactions in intestinal inflammation publication-title: Curr Opin Pharmacol – volume: 127 start-page: 635 year: 2004 end-page: 57 article-title: Enteric neuroimmunophysiology and pathophysiology publication-title: Gastroenterology – volume: 21 start-page: 665 year: 2009 end-page: 71 article-title: Purinergic contribution to small intestinal afferent hypersensitivity in a murine model of postinfectious bowel disease publication-title: Neurogastroenterol Motil – volume: 194 start-page: 13 year: 1968 end-page: 33 article-title: The origin of acetylcholine released from guinea‐pig intestine and longitudinal muscle strips publication-title: J Physiol – volume: 15 start-page: 1717 year: 2009 end-page: 35 article-title: Purinergic receptors and pain publication-title: Curr Pharm Des – volume: 87 start-page: 659 year: 2007 end-page: 797 article-title: Physiology and pathophysiology of purinergic neurotransmission publication-title: Physiol Rev – volume: 332 start-page: 157 year: 1982 end-page: 67 article-title: Evidence that the contractile response of the guinea‐pig ileum to capsaicin is due to release of substance P publication-title: J Physiol – volume: 107 start-page: 262 year: 2012 end-page: 72 article-title: Serum and colonic mucosal immune markers in irritable bowel syndrome publication-title: Am J Gastroenterol – volume: 51 start-page: i41 issue: Suppl. 1 year: 2002 end-page: 4 article-title: A role for inflammation in irritable bowel syndrome? publication-title: Gut – volume: 192 start-page: 49 year: 2007 end-page: 56 article-title: ATP plays a role in neurite stimulation with activated mast cells publication-title: J Neuroimmunol – volume: 38 start-page: 1590 year: 1993 end-page: 5 article-title: Terminal ileal mucosal mast cells in irritable bowel syndrome publication-title: Dig Dis Sci – volume: 272 start-page: G1451 year: 1997 end-page: 6 article-title: Effects of the inflammatory mediator prostaglandin E2 on myenteric neurons in guinea pig ileum publication-title: Am J Physiol – volume: 111 start-page: 671 year: 1989 end-page: 4 article-title: A patient questionnaire to identify bowel disease publication-title: Ann Intern Med – volume: 22 start-page: 4767 year: 2002 end-page: 75 article-title: ATP as a putative sensory mediator: activation of intrinsic sensory neurons of the myenteric plexus via P2X receptors publication-title: J Neurosci – volume: 30 start-page: 245 year: 2009 end-page: 52 article-title: Effect of mesalazine on mucosal immune biomarkers in irritable bowel syndrome: a randomized controlled proof‐of‐concept study publication-title: Aliment Pharmacol Ther – volume: 18 start-page: 6 year: 2006 end-page: 17 article-title: Functional gastrointestinal disorders and mast cells: implications for therapy publication-title: Neurogastroenterol Motil – volume: 17 start-page: 281 year: 2005 end-page: 9 article-title: Human mast cell mediator cocktail excites neurons in human and guinea‐pig enteric nervous system publication-title: Neurogastroenterol Motil – year: 2011 article-title: Bacterial proteases in IBD and IBS publication-title: Gut – volume: 34 start-page: 92 year: 2011 end-page: 9 article-title: Colonic mast cells in controls and slow transit constipation patients publication-title: Aliment Pharmacol Ther – volume: 22 start-page: 1 year: 2010 article-title: Submucous rather than myenteric neurons are activated by supernatants of mucosal biopsies from IBS patients publication-title: Neurogastroenterol Motil – volume: 45 start-page: II43 issue: Suppl. 2 year: 1999 end-page: 7 article-title: Functional bowel disorders and functional abdominal pain publication-title: Gut – ident: e_1_2_10_9_2 doi: 10.1111/j.1365-2982.2005.00685.x – ident: e_1_2_10_47_2 doi: 10.1016/j.tips.2007.08.003 – ident: e_1_2_10_49_2 doi: 10.1159/000268131 – ident: e_1_2_10_40_2 doi: 10.1053/j.gastro.2004.02.017 – ident: e_1_2_10_23_2 doi: 10.1136/gut.2004.048876 – ident: e_1_2_10_21_2 doi: 10.1016/0014-2999(96)00037-4 – volume: 272 start-page: G1451 year: 1997 ident: e_1_2_10_41_2 article-title: Effects of the inflammatory mediator prostaglandin E2 on myenteric neurons in guinea pig ileum publication-title: Am J Physiol contributor: fullname: Dekkers JA – ident: e_1_2_10_8_2 doi: 10.1136/gut.2006.100594 – ident: e_1_2_10_39_2 doi: 10.1113/jphysiol.1982.sp014407 – ident: e_1_2_10_19_2 doi: 10.1113/jphysiol.1968.sp008392 – ident: e_1_2_10_27_2 doi: 10.1182/blood.V97.3.587 – ident: e_1_2_10_25_2 doi: 10.1152/physrev.00043.2006 – ident: e_1_2_10_16_2 doi: 10.1136/gut.2008.169250 – ident: e_1_2_10_28_2 doi: 10.1111/j.1476-5381.2009.00287.x – ident: e_1_2_10_7_2 doi: 10.1007/BF01303164 – ident: e_1_2_10_37_2 doi: 10.1016/j.ejphar.2004.07.020 – ident: e_1_2_10_51_2 doi: 10.1097/00042737-200410000-00010 – ident: e_1_2_10_18_2 doi: 10.7326/0003-4819-111-8-671 – year: 2011 ident: e_1_2_10_24_2 article-title: Bacterial proteases in IBD and IBS publication-title: Gut contributor: fullname: Steck N – ident: e_1_2_10_38_2 doi: 10.1007/s00210-005-0021-6 – ident: e_1_2_10_45_2 doi: 10.1038/ajg.2008.94 – ident: e_1_2_10_2_2 doi: 10.1053/j.gastro.2005.11.061 – ident: e_1_2_10_48_2 doi: 10.1056/NEJMcp0801447 – ident: e_1_2_10_17_2 doi: 10.1136/gut.45.2008.ii43 – ident: e_1_2_10_43_2 doi: 10.1111/j.1365-2982.2008.01100.x – ident: e_1_2_10_15_2 doi: 10.1111/j.1365-2036.2011.04684.x – ident: e_1_2_10_22_2 doi: 10.1111/j.1365-2982.2004.00591.x – ident: e_1_2_10_4_2 doi: 10.1111/j.1572-0241.2002.05475.x – ident: e_1_2_10_35_2 doi: 10.1136/gut.2007.138982 – ident: e_1_2_10_30_2 doi: 10.2174/138161209788186335 – ident: e_1_2_10_36_2 doi: 10.1002/cne.10801 – ident: e_1_2_10_32_2 doi: 10.1113/jphysiol.2004.060848 – ident: e_1_2_10_10_2 doi: 10.1172/JCI29255 – ident: e_1_2_10_13_2 doi: 10.1136/gut.2010.213108 – ident: e_1_2_10_12_2 doi: 10.1053/j.gastro.2009.07.005 – ident: e_1_2_10_46_2 doi: 10.1136/gut.29.3.342 – ident: e_1_2_10_6_2 doi: 10.1053/j.gastro.2003.11.055 – ident: e_1_2_10_34_2 doi: 10.1038/sj.bjp.0705768 – volume: 22 start-page: 1 year: 2010 ident: e_1_2_10_44_2 article-title: Submucous rather than myenteric neurons are activated by supernatants of mucosal biopsies from IBS patients publication-title: Neurogastroenterol Motil contributor: fullname: Buhner S – ident: e_1_2_10_5_2 doi: 10.1053/j.gastro.2009.02.074 – ident: e_1_2_10_14_2 doi: 10.1038/ajg.2011.423 – ident: e_1_2_10_31_2 doi: 10.1111/j.1365-2982.2008.01259.x – ident: e_1_2_10_3_2 doi: 10.1136/gut.51.suppl_1.i41 – volume: 293 start-page: 321 year: 2000 ident: e_1_2_10_20_2 article-title: Affinities, selectivities, potencies, and intrinsic activities of natural and synthetic prostanoids using endogenous receptors: focus on DP class prostanoids publication-title: J Pharmacol Exp Ther contributor: fullname: Sharif NA – ident: e_1_2_10_33_2 doi: 10.1523/JNEUROSCI.22-12-04767.2002 – ident: e_1_2_10_26_2 doi: 10.1016/j.jneuroim.2007.09.013 – ident: e_1_2_10_50_2 doi: 10.1111/j.1365-2036.2009.04041.x – ident: e_1_2_10_11_2 doi: 10.1053/j.gastro.2006.11.039 – volume: 266 start-page: G132 year: 1994 ident: e_1_2_10_42_2 article-title: Effects of the inflammatory mediator prostaglandin D2 on submucosal neurons and secretion in guinea pig colon publication-title: Am J Physiol contributor: fullname: Frieling T – ident: e_1_2_10_29_2 doi: 10.1016/S1471-4892(02)00215-1 |
SSID | ssj0006246 |
Score | 2.322789 |
Snippet | Background Mediators released in the mucosal milieu have been suggested to be involved in visceral hypersensitivity and abdominal pain in patients with... Mediators released in the mucosal milieu have been suggested to be involved in visceral hypersensitivity and abdominal pain in patients with irritable bowel... Background Mediators released in the mucosal milieu have been suggested to be involved in visceral hypersensitivity and abdominal pain in patients with... Background Mediators released in the mucosal milieu have been suggested to be involved in visceral hypersensitivity and abdominal pain in patients with... |
SourceID | proquest crossref pubmed wiley istex |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 1118 |
SubjectTerms | Adult Animals Antagonists Biopsy Capsaicin receptors capsazepine Cell activation Cells Cholinergic Neurons - metabolism Colon Colon - immunology Colon - metabolism Colon - pathology Culture Media, Conditioned - pharmacology Enteric nervous system Female Guinea Pigs Humans Hypersensitivity Inflammation inflammatory mucosal mediators Intestinal Mucosa - immunology Intestinal Mucosa - metabolism Intestinal Mucosa - pathology Irritable bowel syndrome Irritable Bowel Syndrome - immunology Irritable Bowel Syndrome - metabolism Irritable Bowel Syndrome - pathology Male Mast cells Mast Cells - immunology Mast Cells - metabolism Mast Cells - pathology Motor neurons Motor Neurons - metabolism Mucosa Muscles myenteric plexus Myenteric Plexus - metabolism Neurons prostaglandin D2 prostaglandin receptors Purine P2X receptors Rodents Serine proteinase twitch contractions |
Title | Colonic mucosal mediators from patients with irritable bowel syndrome excite enteric cholinergic motor neurons |
URI | https://api.istex.fr/ark:/67375/WNG-6MBZLNHL-5/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fnmo.12000 https://www.ncbi.nlm.nih.gov/pubmed/22937879 https://www.proquest.com/docview/1197415678 https://search.proquest.com/docview/1257748221 |
Volume | 24 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwED_BkBAvG9tgZF8yCE28BCV20qTiaRsbfVgLEiAQL1YcX6SJ1ZmaVdv--905H9okkJB4S1PXtXy-8-_Odz8DvB0nJq-S3IbSjFTI9CehiVIZWhkVpTSG9mwODUy-ZrOf-ccTpsn50NfCtPwQQ8CNNcPba1bwwjT3lNzN6_cxF5qQ_SUvwZdvqC-DFR7JtrJIpVFIKCbtWIU4i2f45YO96AlP682fgOZD3Oo3ntO1_xryc1jt8KY4bBfIOjxCtwGbh4587fmtOBA-A9SH1jfg6bQ7aN8Ed0zv3Hkp5pzRTh34ChO-mUdwQYro6FgbwXFccb7gEIO5QGHqa7wQPQ2CwJuSIK1g3k-yt4JNrS825I5r6k14Ok3XvIDvpyffjidhdzVDWCaEAcjrJIONFUk1yyO0qbJZbJQ1ViUmwxhThkWqkiYuygTJS0JV0GesjImjCqV6CSuudvgKBJY246OgShIWwqg0aW5NmctxElsZV-MA3vRC0pctA4fuPReaUO0nNIADL76hRbH4zSlrWap_zD7p0fTo19lscqbTAHZ7-epOWxvNR6nsyGZ5AK-Hr0nP-PCkcFgvqQ3ZtiwhOBUHsNWui-HPJGEmMnw01Hde_H8fp55NP_uH7X9vugPPCKXJNodmF1auFkvcg8eNXe77JX8HUzcDLA |
link.rule.ids | 315,782,786,1408,27933,27934,46064,46488 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3fb9MwED6xTQJeGGzAwgYYhCZeghI7aVJpL2NsFNEGJIZAvFhxfJGmrQ5qqRj__e6cH2ISSEi8panrWj7f-bvz3WeAF-PE5HWS21CakQqZ_iQ0USpDK6OyksbQns2hgcmnrPiavzlmmpyDvham5YcYAm6sGd5es4JzQPo3LXfz5lXMlSZrsJGMaCFyAYf6ONjhkWxri1QahYRj0o5XiPN4hp9e2402eGIv_wQ1ryNXv_WcbP7foO_CnQ5yisN2jdyDG-i2YPvQkbs9_yX2hU8C9dH1Lbg5687at8Ed0Tt3Vok5J7VTB77IhC_nEVyTIjpG1qXgUK44W3CUwVygMM1PvBA9E4LAy4pQrWDqTzK5gq2trzfkjhvqTXhGTbe8D59Pjk-PJmF3O0NYJQQDyPEkm401CTbLI7SpsllslDVWJSbDGFNGRqqWJi6rBMlRQlXSZ6yNiaMapXoA665xuAMCK5vxaVAtCQ5hVJk0t6bK5TiJrYzrcQDPeynp7y0Jh-6dF5pQ7Sc0gH0vv6FFuTjnrLUs1V-Kt3o0e_1tWkymOg1grxew7hR2qfk0lX3ZLA_g2fA1qRqfn5QOmxW1IfOWJYSo4gAetgtj-DNJsIlsHw31pZf_38epi9kH__Do35s-hVuT09lUT98V73fhNoE22abU7MH6j8UKH8Pa0q6e-PV_BaWjB1Q |
linkToPdf | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3db9MwED-xTZp4YbDxkTHAIDTxEpTYSZOKp7GtFNGGSYBAvFhxfJEmVmdqqRj_PXfOh5gEEhJvaeq6ls93_t357meA5-PE5HWS21CakQqZ_iQ0USpDK6OyksbQns2hgemHrPiSn5wyTc6rvham5YcYAm6sGd5es4Jf2vo3JXeL5mXMhSYbsJUQDGfifKXOBjM8km1pkUqjkGBM2tEKcRrP8NNrm9EWz-vVn5DmdeDqd57Jzn-N-Tbc6gCnOGpXyB24gW4X9o4cOduLn-JQ-BRQH1vfhe15d9K-B-6Y3rnzSiw4pZ068CUmfDWP4IoU0fGxrgQHcsX5kmMM5gKFaX7gheh5EAReVYRpBRN_ksEVbGt9tSF33FBvwvNputVd-DQ5_Xg8Dbu7GcIqIRBAbidZbKxJrFkeoU2VzWKjrLEqMRnGmDIuUrU0cVklSG4SqpI-Y21MHNUo1T3YdI3DByCwshmfBdWSwBBGlUlza6pcjpPYyrgeB_CsF5K-bCk4dO-60IRqP6EBHHrxDS3K5TfOWctS_bl4o0fz119nxXSm0wAOevnqTl1Xms9S2ZPN8gCeDl-TovHpSemwWVMbMm5ZQngqDuB-uy6GP5MEmsjy0VBfePH_fZy6mL_3D_v_3vQJbJ-dTPTsbfHuIdwkxCbbfJoD2Py-XOMj2FjZ9WO_-n8BcIoF-g |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Colonic+mucosal+mediators+from+patients+with+irritable+bowel+syndrome+excite+enteric+cholinergic+motor+neurons&rft.jtitle=Neurogastroenterology+and+motility&rft.au=Balestra%2C+B.&rft.au=Vicini%2C+R.&rft.au=Cremon%2C+C.&rft.au=Zecchi%2C+L.&rft.date=2012-12-01&rft.pub=Blackwell+Publishing+Ltd&rft.issn=1350-1925&rft.eissn=1365-2982&rft.volume=24&rft.issue=12&rft.spage=1118&rft.epage=e570&rft_id=info:doi/10.1111%2Fnmo.12000&rft.externalDBID=10.1111%252Fnmo.12000&rft.externalDocID=NMO12000 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1350-1925&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1350-1925&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1350-1925&client=summon |